Log in
The iScreen™ Urine Test Dx Drug Screen Square Cup uses lateral flow chromatographic immunoassay technology to qualitatively detect drugs and their metabolites in human urine. After the urine specimen is collected directly into the self-contained cup, the integrated test strips begin analyzing the sample for each targeted drug.
This configuration also performs Specimen Validity Testing by measuring selected urine integrity markers, including Creatinine (CR), pH, and Oxidants (OX). These indicators help determine whether the specimen appears normal or has potentially been diluted or chemically altered.
If the drug concentration is below the established screening cutoff, both the Control (C) and Test (T) lines appear, indicating a negative result. If the drug concentration is at or above the cutoff level, only the Control (C) line appears, indicating a preliminary positive result.
Because this device provides preliminary screening results only, any positive finding should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, or employment decisions are made
Amphetamine is a prescription central nervous system (CNS) stimulant commonly prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It increases the activity of certain neurotransmitters in the brain, improving focus, attention, and alertness. However, amphetamine is also widely misused because of its stimulating effects and potential to enhance energy and performance.
Increased energy
Improved alertness
Elevated mood
Reduced appetite
Increased heart rate
Restlessness
Anxiety
Insomnia
Long-term misuse may lead to dependence, cardiovascular complications, and mental health disorders.
Speed, Uppers, Bennies, Dexies, Pep Pills, Addys.
Amphetamine is generally detectable in urine for approximately 2–4 days after use
Barbiturates are central nervous system depressants prescribed for the treatment of seizure disorders, anxiety, insomnia, and as anesthetic agents in certain medical procedures. Although their medical use has declined due to safer alternatives, they still carry a significant risk of misuse, dependence, and overdose.
Sedation
Relaxation
Drowsiness
Slurred speech
Poor coordination
Dizziness
Confusion
Slowed breathing
Long-term misuse may result in dependence, respiratory depression, and overdose.
Barbs, Downers, Reds, Blues, Yellow Jackets, Rainbows.
Barbiturates are generally detectable in urine for 2–7 days, although some long-acting barbiturates may remain detectable for longer
Buprenorphine is a partial opioid agonist commonly prescribed for the treatment of opioid dependence and moderate to severe pain. It is widely used in medication-assisted treatment (MAT) programs because it helps reduce opioid cravings and withdrawal symptoms while producing fewer euphoric effects than full opioid agonists. Despite its therapeutic benefits, buprenorphine may still be misused and is routinely included in professional drug testing panels.
Pain relief
Reduced opioid cravings
Relaxation
Drowsiness
Dizziness
Nausea
Sweating
Constipation
Long-term misuse may result in physical dependence and respiratory depression.
Subs, Bupe, Subutex, Suboxone.
Buprenorphine is generally detectable in urine for approximately 3–7 days after use
Benzodiazepines are prescription medications that depress the central nervous system and are commonly used to treat anxiety disorders, panic attacks, insomnia, muscle spasms, and seizures. While highly effective when used appropriately, prolonged or non-medical use can lead to tolerance, dependence, and misuse.
Relaxation
Reduced anxiety
Drowsiness
Muscle relaxation
Slowed reaction time
Dizziness
Memory impairment
Poor coordination
Long-term misuse may lead to dependence, withdrawal symptoms, and overdose, especially when combined with other CNS depressants.
Benzos, Xannies, Bars, Valium, K-Pins.
Benzodiazepines are generally detectable in urine for approximately 3–7 days, while certain long-acting medications may remain detectable for several weeks.
Cocaine is a powerful central nervous system stimulant derived from the coca plant. It produces short-lived feelings of euphoria, increased confidence, and heightened alertness by increasing dopamine levels in the brain. Cocaine has a high potential for abuse and addiction and is routinely included in workplace, clinical, and forensic drug testing panels.
Increased energy
Euphoria
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Restlessness
Long-term misuse may contribute to heart attack, stroke, depression, and substance dependence.
Coke, Blow, Snow, Crack, Rock, Flake, Yayo, White.
Cocaine is generally detectable in urine for approximately 2–4 days after use.
MDMA (3,4-Methylenedioxymethamphetamine), commonly known as Ecstasy or Molly, is a synthetic psychoactive substance with both stimulant and mild hallucinogenic properties. It increases serotonin, dopamine, and norepinephrine levels in the brain, producing feelings of euphoria, emotional warmth, and increased energy. MDMA is commonly encountered in recreational settings and is included in many professional drug screening panels.
Euphoria
Increased energy
Emotional warmth
Enhanced sensory perception
Increased heart rate
Sweating
Jaw clenching
Dehydration
Long-term misuse may contribute to anxiety, depression, sleep disturbances, and memory problems.
Ecstasy, Molly, X, E, Beans, Adam, Love Drug.
MDMA is generally detectable in urine for approximately 2–4 days after use.
Methamphetamine is a powerful central nervous system (CNS) stimulant that affects the brain and nervous system. Although it has limited medical uses, it is most commonly associated with illicit drug abuse because of its highly addictive nature. Methamphetamine increases dopamine levels in the brain, producing intense feelings of euphoria, increased energy, and heightened alertness.
Increased energy
Heightened alertness
Euphoria
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Aggressive behavior
Long-term misuse may lead to addiction, severe weight loss, paranoia, hallucinations, memory problems, and cardiovascular complications.
Meth, Crystal Meth, Ice, Glass, Tina, Crank.
Methamphetamine is generally detectable in urine for approximately 2–5 days after use.
Morphine is a naturally occurring opioid medication used to relieve moderate to severe pain. Opiates include drugs such as morphine and codeine, while some screening panels also detect related opioid compounds. Although these medications have legitimate medical uses, they are frequently misused because of their pain-relieving and euphoric effects.
Pain relief
Relaxation
Euphoria
Drowsiness
Constricted pupils
Slowed breathing
Nausea
Constipation
Long-term misuse may result in opioid dependence, overdose, respiratory depression, and death.
Smack, Dope, H, Horse, Junk, Mud.
Morphine and other opiates are generally detectable in urine for approximately 2–3 days after use.
Methadone is a long-acting synthetic opioid commonly prescribed to treat chronic pain and opioid dependence. It is widely used in medication-assisted treatment (MAT) programs to reduce withdrawal symptoms and opioid cravings. While effective under medical supervision, methadone also has the potential for misuse and dependence.
Pain relief
Relaxation
Drowsiness
Reduced opioid cravings
Slowed breathing
Sweating
Dizziness
Nausea
Long-term misuse may result in dependence, overdose, respiratory depression, and irregular heartbeat.
Fizzies, Dollies, Juice, Amidone, Methadose.
Methadone is generally detectable in urine for approximately 3–7 days after use
Oxycodone is a semi-synthetic opioid analgesic prescribed for moderate to severe pain. It is commonly used following surgery, injury, or for chronic pain management. Due to its strong pain-relieving effects, oxycodone is also one of the most frequently misused prescription opioids.
Pain relief
Euphoria
Relaxation
Drowsiness
Slowed breathing
Dizziness
Nausea
Constipation
Long-term misuse may lead to opioid dependence, overdose, respiratory depression, and death.
Oxy, OCs, Percs, Roxies, Hillbilly Heroin.
Oxycodone is generally detectable in urine for approximately 2–4 days after use
Phencyclidine (PCP), commonly known as Angel Dust, is a dissociative hallucinogenic drug originally developed as a surgical anesthetic. Its medical use was discontinued because of severe psychological side effects, but it continues to be abused because of its powerful mind-altering effects.
Hallucinations
Detachment from reality
Confusion
Aggressive behavior
Numbness
Loss of coordination
Elevated blood pressure
Agitation
Heavy use may result in psychosis, seizures, coma, and death.
Angel Dust, Sherm, Wet, Rocket Fuel, Love Boat, Embalming Fluid.
PCP is generally detectable in urine for approximately 7–14 days, depending on the frequency of use
Tricyclic antidepressants (TCAs) are prescription medications primarily used to treat depression, chronic pain, migraine prevention, and certain anxiety disorders. While effective for several medical conditions, excessive use or overdose can produce serious cardiovascular and neurological complications. Drug screening panels may include TCA detection to identify potential misuse or overdose.
Improved mood (when prescribed)
Drowsiness
Dry mouth
Blurred vision
Constipation
Dizziness
Increased heart rate
Confusion
Amitriptyline
Nortriptyline
Imipramine
Desipramine
Doxepin
Tricyclic antidepressants are generally detectable in urine for approximately 2–7 days, depending on the specific medication and individual metabolism
The iScreen™ Urine Test Dx Drug Screen Square Cup (12 Panel with Adulterant Testing) provides a comprehensive and convenient solution for rapid, on-site urine drug screening. Its integrated self-contained collection cup minimizes specimen handling and collector exposure while delivering reliable preliminary results in approximately 5 minutes.
With 12 drug panels and built-in Specimen Validity Testing (Creatinine, pH, and Oxidants), the device helps verify specimen integrity while screening for a broad range of commonly abused substances. Designed for professional in vitro diagnostic use, it is well suited for workplace testing, healthcare facilities, rehabilitation programs, occupational health clinics, and forensic environments. As with all rapid immunoassay screening devices, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, or employment decisions are made.
The iScreen™ Urine Test Dx Drug Screen Square Cup is a convenient, all-inclusive urine drug screening device designed for rapid, on-site detection of multiple drugs of abuse. This self-contained collection and testing system simplifies the specimen collection process while helping minimize collector exposure to urine. The integrated test cup delivers fast, reliable preliminary results in approximately 5 minutes, making it ideal for professional point-of-care testing.
Designed for workplace, clinical, rehabilitation, and forensic applications, the iScreen™ Urine Test Dx Drug Screen Square Cup combines specimen collection and drug screening into a single, easy-to-use device. The integrated cup design helps reduce specimen handling while improving testing efficiency and maintaining sample integrity throughout the screening process.
This 12-panel configuration simultaneously screens for Amphetamine (AMP), Barbiturates (BAR), Buprenorphine (BUP), Benzodiazepines (BZO), Cocaine (COC), MDMA (Ecstasy), Methamphetamine (MET/mAMP), Morphine/Opiates (MOP/OPI), Methadone (MTD), Oxycodone (OXY), Phencyclidine (PCP), and Tricyclic Antidepressants (TCA) from a single urine specimen.
In addition to drug detection, this configuration includes Specimen Validity (Adulterant) Testing to help identify urine samples that may have been diluted, substituted, or adulterated before testing. This version includes validity testing for:
The iScreen™ Urine Test Dx Drug Screen Square Cup provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using a more specific laboratory method such as Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, or employment decisions are made.
The device is intended for in vitro diagnostic use only, with CLIA-waived configurations available for qualifying testing environments
This 12 Panel configuration screens for:
This version also includes:
Drug
Typical Urine Detection Window
Amphetamine (AMP)
2–4 Days
Barbiturates (BAR)
2–7 Days
Buprenorphine (BUP)
3–7 Days
Benzodiazepines (BZO)
3–7 Days*
Cocaine (COC)
2–4 Days
MDMA
2–4 Days
Methamphetamine (MET)
2–5 Days
Morphine / Opiates (MOP/OPI)
2–3 Days
Methadone (MTD)
3–7 Days
Oxycodone (OXY)
2–4 Days
Phencyclidine (PCP)
7–14 Days
Tricyclic Antidepressants (TCA)
2–7 Days
*Some long-acting benzodiazepines may remain detectable for several weeks
A colored line appears in both the Control (C) and Test (T) regions for each drug. Even a faint Test (T) line should be interpreted as a negative result, indicating that the drug concentration is below the screening cutoff.
A colored line appears only in the Control (C) region, while no line appears in the corresponding Test (T) region. This indicates that the drug concentration may be at or above the cutoff level. All preliminary positive results should be confirmed using GC-MS or LC-MS/MS.
If no Control (C) line appears, the test is invalid regardless of the Test line. A new test should be performed using a fresh device and specimen
This configuration includes Specimen Validity Testing (SVT) to help identify urine samples that may have been diluted, substituted, or chemically altered before testing.
Measures creatinine concentration to help determine whether the urine specimen is excessively diluted.
Measures the acidity or alkalinity of the urine specimen. Abnormal pH values may indicate specimen adulteration.
Detects oxidizing agents or bleach that may be added to urine in an attempt to interfere with drug test results.
iScreen™ 12 Panel Dx Drug Screen Square Cup with Adulterant Test | Abbott | AMP, BAR, BUP, BZO, COC, MDMA, MET/mAMP, MOP/OPI, MTD, OXY, PCP, TCA | ABTDUAW112704D 25/Box
Sign up for updates from leading retailers
